Kenneth L. Londoner - 01 Sep 2021 Form 4 Insider Report for BioSig Technologies, Inc. (BSGM)

Role: Chief Executive Officer, Director
Signature: /s/ Kenneth L. Londoner, attorney-in-fact
Issuer symbol: BSGM
Transactions as of: 01 Sep 2021
Net transactions value: +$19,802
Form type: 4
Filing time: 01 Sep 2021, 12:48:22 UTC
Previous filing: 31 Aug 2021
Next filing: 29 Sep 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BSGM	Common Stock	Purchase	$19,802	+6,400	+0.38%	$3.09^*	1,705,058	01 Sep 2021	Direct	F1
holding	BSGM	Common Stock						1,181,324	01 Sep 2021	By Endicott Management Partners, LLC	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.08 to $3.11, inclusive. The reporting person undertakes to provide to BioSig Technologies, Inc., any security holder of BioSig Technologies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
F2	The Reporting Person is the beneficial owner of Endicott Management Partners, LLC.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.08 to $3.11, inclusive. The reporting person undertakes to provide to BioSig Technologies, Inc., any security holder of BioSig Technologies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.

The Reporting Person is the beneficial owner of Endicott Management Partners, LLC.